In the present study, it was revealed that curcumin treatment inhibited the expression of TGF-β1/smad3 signaling pathway-related proteins, indicating that the curcumin inhibited the malignant phenotype of HCC partially by inhibiting TGF-β1/smad3 signaling pathway. The gene discussed is SMAD3; the disease is hepatocellular carcinoma.